WANY
OGN icon

Wealthspire Advisors (New York)’s Organon & Co OGN Stock Holding History

Wealthspire Advisors (New York)’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-2,931
Closed -$31.3K – 2282
2025
Q3 		$31.3K Buy
+2,931
New +$28.8K ﹤0.01% 1438

Other funds holding OGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return

Wealthspire Advisors (New York)'s OGN Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Organon & Co (OGN) in Q4 2025, closing a stake of 2,931 shares — an estimated $31.3K sold.

Wealthspire Advisors (New York) first reported a position in OGN in Q3 2025 and held it in 1 quarter. The position peaked at $31.3K in Q3 2025. 634 funds tracked by Wall St. Rank hold OGN as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Organon & Co position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 2,931 Organon & Co shares in Q4 2025, an estimated $31.3K.
  • Wealthspire Advisors (New York) first reported a position in Organon & Co in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s Organon & Co position peaked at $31.3K in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Organon & Co as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.